Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
JYSB2200187	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2022-09-29	Novo Nordisk A/S	view
CXSL2101158	德谷胰岛素注射液	insulin degludec	Injection	Biological Products(3.3)	New Drug Application	2021-06-29	Beijing SL Pharmaceutical Co Ltd	view
CYSB2200227	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2022-09-15	Novo Nordisk (China) Pharmaceuticals Co Ltd	view
CXSL2200317	德谷胰岛素注射液	insulin degludec	Injection	Biological Products(3.3)	New Drug Application	2022-07-14	Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd	view
CXSS2400109	德谷胰岛素注射液	insulin degludec	Injection	Biological Products(3.3)	New Drug Application	2024-10-12	Zhuhai Federal Biomedical Co Ltd	view
CYSB2101269	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2021-11-10	Novo Nordisk (China) Pharmaceuticals Co Ltd	view
JYSB2101167	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2021-11-10	Novo Nordisk A/S	view
CXSL2200318	德谷胰岛素注射液	insulin degludec	Injection	Biological Products(3.3)	New Drug Application	2022-07-25	Tonghua Dongbao Pharmaceutical Co Ltd	view
JYSB2101153	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2021-10-22	Novo Nordisk A/S	view
CXSL2400293	德谷胰岛素注射液	insulin degludec	Injection	Biological Products(3.3)	New Drug Application	2024-05-09	Shandong New Time Pharmaceutical Co Ltd	view
CXSS2500030	德谷胰岛素注射液	insulin degludec	Injection	Biological Products(3.3)	New Drug Application	2025-02-20	Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd	view
CYSB2101172	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2021-08-31	Novo Nordisk (China) Pharmaceuticals Co Ltd	view
CYSB2200226	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2022-09-15	Novo Nordisk (China) Pharmaceuticals Co Ltd	view
CXSS2200066	德谷胰岛素注射液	insulin degludec	Injection	Biological Products(3.3)	New Drug Application	2022-07-15	Jilin Huisheng Biopharmaceutical Co Ltd	view
CXSL2300433	德谷胰岛素注射液	insulin degludec	Injection	Biological Products(3.3)	New Drug Application	2023-06-27	Fosun Wanbang (Jiangsu) Pharmaceutical Group Co Ltd	view
JYSB2101166	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2021-11-10	Novo Nordisk A/S	view
CXSS2500025	德谷胰岛素注射液	insulin degludec	Injection	Biological Products(3.3)	New Drug Application	2025-02-09	Yichang HEC Changjiang Pharmaceutical Co Ltd	view
JYSZ2200008	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	License Renew	2022-03-04	Novo Nordisk A/S	view
CXSL2101500	德谷胰岛素注射液	insulin degludec	Injection	Biological Products(3.3)	New Drug Application	2021-12-22	Zhuhai GENE-BIOCON Biological Technology Co Ltd	view
JYSB2200188	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2022-09-29	Novo Nordisk A/S	view